Humana Inc
HUM278.170USD
-7.440-2.60%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
33.46BMarket Cap
21.23P/E TTM
More Details of Humana Inc Company
Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.
Humana Inc Info
Ticker SymbolHUM
Company nameHumana Inc
IPO dateMay 18, 1971
CEOMr. James A. (Jim) Rechtin
Number of employees65680
Security typeOrdinary Share
Fiscal year-endMay 18
Address500 W Main St
CityLOUISVILLE
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code40202
Phone15025801000
Websitehttps://www.humana.com/
Ticker SymbolHUM
IPO dateMay 18, 1971
CEOMr. James A. (Jim) Rechtin
Company Executives of Humana Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
20.63K
--
Mr. Kurt J. Hilzinger
Mr. Kurt J. Hilzinger
Independent Chairman of the Board
Independent Chairman of the Board
19.45K
--
Mr. Joseph Christopher (Joe) Ventura
Mr. Joseph Christopher (Joe) Ventura
Chief Legal Officer
Chief Legal Officer
17.32K
+48.83%
Dr. Vishal Agrawal, M.D.
Dr. Vishal Agrawal, M.D.
Chief Strategy and Corporate Development Officer
Chief Strategy and Corporate Development Officer
16.72K
+35.01%
Mr. Jorge S. Mesquita
Mr. Jorge S. Mesquita
Independent Director
Independent Director
2.58K
+55.96%
Mr. John W. Garratt
Mr. John W. Garratt
Independent Director
Independent Director
1.69K
+34.26%
Ms. Karen W. Katz
Ms. Karen W. Katz
Independent Director
Independent Director
590.00
--
Dr. David T. Feinberg, M.D.
Dr. David T. Feinberg, M.D.
Independent Director
Independent Director
441.00
--
Ms. Marcy S. Klevorn
Ms. Marcy S. Klevorn
Independent Director
Independent Director
436.00
--
Mr. Brad D. Smith
Mr. Brad D. Smith
Independent Director
Independent Director
386.00
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
20.63K
--
Mr. Kurt J. Hilzinger
Mr. Kurt J. Hilzinger
Independent Chairman of the Board
Independent Chairman of the Board
19.45K
--
Mr. Joseph Christopher (Joe) Ventura
Mr. Joseph Christopher (Joe) Ventura
Chief Legal Officer
Chief Legal Officer
17.32K
+48.83%
Dr. Vishal Agrawal, M.D.
Dr. Vishal Agrawal, M.D.
Chief Strategy and Corporate Development Officer
Chief Strategy and Corporate Development Officer
16.72K
+35.01%
Mr. Jorge S. Mesquita
Mr. Jorge S. Mesquita
Independent Director
Independent Director
2.58K
+55.96%
Mr. John W. Garratt
Mr. John W. Garratt
Independent Director
Independent Director
1.69K
+34.26%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Premiums
30.72B
94.84%
Service
1.40B
4.32%
Investment income
272.00M
0.84%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Premiums
30.72B
94.84%
Service
1.40B
4.32%
Investment income
272.00M
0.84%
Shareholding Stats
Updated: Thu, Oct 30
Updated: Thu, Oct 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.76%
Dodge & Cox
9.44%
BlackRock Institutional Trust Company, N.A.
5.22%
State Street Investment Management (US)
4.47%
Pzena Investment Management, LLC
3.39%
Other
65.72%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.76%
Dodge & Cox
9.44%
BlackRock Institutional Trust Company, N.A.
5.22%
State Street Investment Management (US)
4.47%
Pzena Investment Management, LLC
3.39%
Other
65.72%
Shareholder Types
Shareholders
Proportion
Investment Advisor
43.15%
Investment Advisor/Hedge Fund
39.35%
Hedge Fund
8.98%
Pension Fund
2.88%
Bank and Trust
2.55%
Research Firm
2.32%
Sovereign Wealth Fund
1.42%
Individual Investor
0.23%
Family Office
0.06%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2187
115.83M
96.30%
-9.66M
2025Q2
2257
114.76M
95.42%
-19.25M
2025Q1
2321
116.64M
96.64%
-15.71M
2024Q4
2306
118.51M
98.19%
-7.58M
2024Q3
2271
114.45M
95.04%
-13.07M
2024Q2
2270
116.19M
96.50%
-5.74M
2024Q1
2237
112.35M
93.21%
-8.14M
2023Q4
2219
114.70M
93.84%
-10.54M
2023Q3
2136
116.47M
94.60%
-6.57M
2023Q2
2114
117.98M
95.21%
-8.26M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
14.14M
11.76%
+223.18K
+1.60%
Jun 30, 2025
Dodge & Cox
11.35M
9.44%
+597.71K
+5.56%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
6.28M
5.22%
-328.94K
-4.97%
Jun 30, 2025
State Street Investment Management (US)
5.38M
4.47%
+58.09K
+1.09%
Jun 30, 2025
Pzena Investment Management, LLC
4.08M
3.39%
+247.74K
+6.47%
Jun 30, 2025
Eagle Capital Management L.L.C.
3.95M
3.28%
+806.19K
+25.65%
Jun 30, 2025
Geode Capital Management, L.L.C.
3.13M
2.6%
+57.27K
+1.86%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.61M
2.17%
+518.01K
+24.72%
Jun 30, 2025
Sessa Capital
2.12M
1.77%
+1.74M
+458.42%
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
6%
Monarch Volume Factor Dividend Tree Index ETF
3.68%
Eagle Capital Select Equity ETF
3.5%
American Customer Satisfaction ETF
3.08%
Davis Select US Equity ETF
2.81%
SPDR S&P Health Care Services ETF
2.56%
Bushido Capital US Equity ETF
2.44%
VictoryShares Free Cash Flow ETF
2.24%
Invesco S&P 500 Equal Weight Health Care ETF
2.16%
First Trust Health Care Alphadex Fund
2.14%
View more
iShares U.S. Healthcare Providers ETF
Proportion6%
Monarch Volume Factor Dividend Tree Index ETF
Proportion3.68%
Eagle Capital Select Equity ETF
Proportion3.5%
American Customer Satisfaction ETF
Proportion3.08%
Davis Select US Equity ETF
Proportion2.81%
SPDR S&P Health Care Services ETF
Proportion2.56%
Bushido Capital US Equity ETF
Proportion2.44%
VictoryShares Free Cash Flow ETF
Proportion2.24%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion2.16%
First Trust Health Care Alphadex Fund
Proportion2.14%
Dividend
A total of
1.93B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 20, 2025
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Oct 24, 2024
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 15, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Oct 25, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 25, 2024
Sep 30, 2024
Apr 18, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 15, 2024
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 26, 2024
Mar 27, 2024
Nov 02, 2023
HUM.NB Final Cash Dividend of gross USD 0.885 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Aug 17, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Oct 27, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 27, 2023
Sep 28, 2023
Apr 20, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Jul 28, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 28, 2023
Jun 29, 2023
Feb 16, 2023
HUM.NB Interim Cash Dividend of gross USD 0.885 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Oct 27, 2022
HUM.NB Final Cash Dividend of gross USD 0.7875 paid on Jan 27, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 27, 2023
Dec 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
